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1118-83 Pathological Features Found Postmortem in 53 Patients 
With Cardiac Rupture Complicating Acute Myocardial 
Infarction
Satoshi Yasuda, Yasuhide Asaumi, Hiroyuki Okumura, Yoritaka Otsuka, Isao Morii, 
Atsushi Kawamura, Chikao Yutani, Hiroshi Nonogi, Shunichi Miyazaki, National 
Cardiovascular Center, Osaka, Japan
Background: Cardiac rupture is responsible for about 15% of all in-hospital deaths
among patients with acute myocardial infarction (AMI). However, information regarding
the clinical profile and pathological features of this fatal complication is limited.
Methods: We studied 53 consecutive patients with AMI (M/F; 32/21, age; 73±7
[mean±SD] years), who died of ventricular septal and free wall rupture between 1978 and
2002. The diagnosis was made based on postmortem histological examination. Forty-
two patients (80%) were without previous infarction and 44 patients (84%) were hyper-
tensive.
Results: Cardiac rupture occurred acutely within 48 hours of AMI onset in 20 patients
(38%). Also, it occurred 6-8 days after the onset of AMI in 17 patients (32%), in whom
immunohistochemical studies revealed accumulation of inflammatory cells and activation
of matrix metalloproteinases at the rupture site. AMI-related artery was the left anterior
descending artery in 37 patients (70%), the right coronary artery in 13 patients (25%)
and the left circumflex artery in 3 patients (5%). In most patients (n=48, 91%), the AMI-
related vessel was totally or subtotally occluded. Since 1993, the era in which the reper-
fusion therapy has been developed, the total number of rupture patients has been
decreasing, but the percentage of those with hemorrhagic infarction has been increasing;
1978–82, n=12 (17%); 1983-87, n=14 (29%); 1988-92, n=14 (36%); 1993-97, n=7 (57%);
1998-2002, n=6 (50%).
Conclusions: These findings indicate the potential importance of revascularization of
the AMI-related artery to reduce the risk of cardiac rupture. Histologically, sustained
inflammatory responses with metalloprotease activation may contribute to modulating the
wound-healing process following infarction.
1118-84 Is the Timing of Coronary Artery Bypass Graft Surgery 
Following Acute Myocardial Infarction Associated With 
a Difference in Mortality?
Michael Mack, Marc Katz, Aaron Kugelmass, J. James Zocco, Timonthy Wolfgang, 
Thomas Christopher, Edmund Becker, Steven Culler, April Simon, Emory University, 
Atlanta, GA, CRSTI, Dallas, TX
Background: This study examines association between operative and predicted mortal-
ity rates and the length of time between a preoperative myocardial infarction (MI) and cor-
onary artery bypass graft surgery (CABG) in patients treated in community hospitals.
Methods: The study sample consists of 5,465 consecutive patients who underwent
CABG only in one of 18 community hospitals. Logistic regression analysis was utilized to
determine if selected time intervals ( 21 days) between a preoperative MI and CABG
were statistically associated with operative mortality after controlling for 30 demographic,
procedural and cardiac risk factors.
Results: Approximately 42% of the sample had an MI prior to CABG. Patient’s whose
CABG was performed within the first 24 hours had significantly higher mortality rates
than those observed for patients whose CABG was delayed by at least 24 hours (see
table). Controlling for demographic, procedural and cardiac risk factors, patient’s whose
CABG was performed within the first 24 hours were 2.7 times (p=0.024) more likely to die
during their hospitalization than patients having surgery between 1 and 7 days after their
MI.
Conclusions: Operative mortality is highest if CABG is performed within the first 24 hrs
of MI, but there is no difference between any of the other MI groups (1-7 days, 8-21 days,
or > 21 days). Further research needs to assess the clinical imperative for surgery within
the first 24 hrs. 
1118-101 Congestive Heart Failure and Cardiogenic Shock 
Complicating Acute Myocardial Infarction Have High 
Mortality and Are Associated With Intense Inflammatory 
Response: Results From the CARDINAL Trials
Rafael Valencia, Pierre Theroux, Christopher B. Granger, Kenneth W. Mahaffey, Taissa 
Gudaye, Kevin Malloy, W. Douglas Weaver, Thomas G. Todaro, Christopher F. Mojcik, 
Paul W. Armstrong, Judith S. Hochman, New York University Medical Center, New York, 
NY
There are limited data on the development, clinical correlates, role of inflammation and
outcomes of CHF and cardiogenic shock (CS) complicating acute ST-elevation MI
(STEMI) in the reperfusion era.
We analyzed data from The Complement and ReDuction of Infarct size after Angioplasty
or Lytics (CARDINAL) program which included fibrinolytic and primary percutaneous cor-
onary intervention (PCI) trials investigating adjunctive pexelizumab, a monoclonal anti-
body against C5 complement, in the management of STEMI. The characteristics and
outcomes of 1903 enrolled patients and a subset of 350 PCI patients with serial inflam-
matory markers and proBNP levels were evaluated.
New or worsening CHF or CS developed in 3% and 4% of patients respectively. Patients
who developed CHF or CS presented with a greater prevalence of diabetes mellitus
(p=0.003). There was an association of increasing heart rate (p<0.001) and decreasing
systolic blood pressure (p<0.001) on presentation and increasing infarct size (area under
the curve for CK MB thru 72 hrs) (p<0.001) with the development of CHF or CS. White
blood cell count at presentation was higher in the group that developed CS (p=0.006).
Higher levels of IL-6, TNF alpha, hsCRP, and proBNP were seen in patients who pre-
sented in CHF or CS. Patients who presented to the hospital without CHF or CS but later
developed new CS had significantly higher levels of IL-6, TNF alpha, and proBNP at pre-
sentation, 24 hours and 72 hours after presentation compared to patients who did not
develop CS. The most striking difference was seen with IL-6 with average values at time
0, 24 and 72 hours of 19, 367, and 199 pg/mL in patients who presented without CHF or
CS but developed new CS compared to patients who did not develop CS whose values
were 11, 50, and 29 pg/mL respectively (p<0.001). Mortality in patients who developed
CS was 61% compared with 13% in patients who developed CHF and 5% in patients
without the development of CHF or CS (p<0.001).
Despite reperfusion therapy, CHF and CS continue to complicate acute STEMI and are
associated with high mortality rates. CHF and to a larger extent, CS, are associated with
a marked inflammatory response which has potential diagnostic and therapeutic implica-
tions.
1118-102 Baseline White Blood Cell Count and Interleukin-6 
Levels Provide Complementary Prognostic Information 
in Acute Myocardial Infarction: Results From the 
CARDINAL Trial
Manesh R. Patel, Kenneth W. Mahaffey, Paul W. Armstrong, W. Douglas Weaver, Gudaye 
Tasissa, Judith S. Hochman, Thomas G. Todaro, Kevin J. Malloy, Thomas H. Parish, 
Scottt Rollins, Pierre Theroux, Wiltold Ruzyllo, Jose C. Nicolau, Christopher B. Granger, 
Duke Clinical Research Institute, Durham, NC
Background: Inflammation plays an important role in pathophysiology of acute coronary
syndromes.
Methods: The relationships between baseline WBC count, interleukin-6 (IL6) levels in a
subset of patients (n=328), and their association with outcomes were analyzed using
data from two trials in the CARDINAL program evaluating pexelizumab (antibody to com-
plement factor C5) in patients with ST elevation myocardial infarction undergoing fibrinol-
ysis (n=934) or primary PCI (n=960). Infarct sizes determined by CKMB area under the
curve and 90-day mortality were analyzed.
Results: Higher WBC counts (highest quartile vs. lowest quartile) at presentation were
associated with younger age (median 56 vs. 62 years), higher proportion of anterior inf-
arcts (82.9% vs. 76.9%), and higher proportion with Killip Class > 1 (22.6% vs. 11.2%)
respectively. Higher WBC count was also associated with larger infarct size (CKMB 5690
vs. 2882 [ng/mL] • h) and development of congestive heart failure and shock (6.6% vs.
2.6%). Mortality at 90-days was significantly related to WBC count (figure, p
value=0.017). Median IL-6 levels tracked with baseline WBC count, highest vs. lowest
quartile(Q4-16 ng/dl vs.Q1-8.3ng/dl IL-6), and subsequent outcomes.
Conclusion: WBC count was directly related to infarct size and mortality. A marker of
inflammation, IL-6 tracked with WBC count and outcomes. The baseline WBC count is a
simple marker of inflammation that provides prognostic information. 
Mortality Rates From Time of MI to CABG
No MI < 24 Hrs. 1-7 Days 8-21 Days > 21 Days
Patients 3,213 103 957 217 975
Operative Mortality 1.7% 19.4% 3.7% 2.8% 3.3%
Predicted Mortality 2.1% 10.7% 4.0% 4.9% 3.3%
